Great West Life Assurance CO Viking Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $58 Billion
- Q4 2024
A detailed history of Great West Life Assurance CO transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 83,579 shares of VKTX stock, worth $2.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
83,579
Previous 84,275
0.83%
Holding current value
$2.47 Million
Previous $5.34 Million
37.1%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding VKTX
# of Institutions
471Shares Held
66.4MCall Options Held
5.88MPut Options Held
3.83M-
Vanguard Group Inc Valley Forge, PA10.2MShares$300 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$178 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$145 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$76.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$63.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.26B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...